Antidote.me
company
About
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
- 51 - 100
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster.Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$50.90M
Antidote.me has raised a total of
$50.90M
in funding over 2 rounds. Their latest funding was raised on
Jun 3, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 3, 2021 | Series Unknown | $23.20M | 1 | — | — | Detail |
| Sep 7, 2017 | Series Unknown | $11M | 1 | — | — | Detail |
| Apr 14, 2016 | Series Unknown | — | 1 |
Octopus Ventures
|
— | Detail |
| Feb 5, 2015 | Series B | $13.50M | 1 | — | — | Detail |
| May 8, 2013 | Series A | $3.20M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Antidote.me is funded by 1 investors.
Octopus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Octopus Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
